Skip to main content
Log in

Leukemic transformation of essential thrombocythemia without previous cytoreductive treatment

  • CASE REPORT
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

 Blastic transformation of essential thrombocythemia (ET) preceded by chemotherapy is occasionally described in the literature. In ET as well as in other myeloproliferative disorders the leukemogenic effect of alkylating agents and 32P is well established, and recent reports also indicate a certain leukemogenic effect of hydroxyurea in these disorders. However, leukemic transformation in untreated ET seems to be a rare event. This is probably due to the fact that, at some time during their clinical course, most ET patients receive chemotherapy and are thereby exposed to leukemogenic challenge. We report on a woman with ET who had not received cytoreductive treatment prior to the development of acute myeloid leukemia, indicating that this transformation was a natural progression of her disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: November 26, 1998 / Accepted: June 2, 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andersson, P., Ridell, B., Wadenvik, H. et al. Leukemic transformation of essential thrombocythemia without previous cytoreductive treatment. Ann Hematol 79, 40–42 (2000). https://doi.org/10.1007/s002770050007

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002770050007

Navigation